MFDS
- Marketing authorisation holder: AYRMID PHARMA
- Status: likely_approved
🇰🇷 Aphexda in South Korea
Aphexda (MOTIXAFORTIDE) regulatory status in South Korea.
Marketing authorisation
Aphexda in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Aphexda approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Aphexda in South Korea?
AYRMID PHARMA holds the South Korean marketing authorisation.